NARS ALL DAY LUMINOUS FOUNDATION SIBERIA- octinoxate and titanium dioxide powder NARS ALL DAY LUMINOUS FOUNDATION MONT BLANC- octinoxate and titanium dioxide powder NARS ALL DAY LUMINOUS FOUNDATION DEAUVILLE- octinoxate and titanium dioxide powder NARS ALL DAY LUMINOUS FOUNDATION SWEDEN- octinoxate and titanium dioxide powder NARS ALL DAY LUMINOUS FOUNDATION FIJI- octinoxate and titanium dioxide powder NARS ALL DAY LUMINOUS FOUNDATION PUNJAB- octinoxate and titanium dioxide powder NARS ALL DAY LUMINOUS FOUNDATION SANTA FE- octinoxate and titanium dioxide powder NARS ALL DAY LUMINOUS FOUNDATION BARCELONA- octinoxate and titanium dioxide powder NARS ALL DAY LUMINOUS FOUNDATION LAPONIE- octinoxate and titanium dioxide powder NARS ALL DAY LUMINOUS FOUNDATION VALLAURIS- octinoxate and titanium dioxide powder

NARS ALL DAY LUMINOUS FOUNDATION by

Drug Labeling and Warnings

NARS ALL DAY LUMINOUS FOUNDATION by is a Otc medication manufactured, distributed, or labeled by NARS COSMETICS. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

SPL UNCLASSIFIED SECTION

Drug Facts

Active ingredients

Octinoxate 4.9%

Titanium Dioxide 8.3%

Purpose

Sunscreen

Uses

• helps prevent sunburn
• if used as directed with other sun protection measures (see Directions), decreases the risk of skin cancer and early skin aging caused by the sun

Warnings

For external use only

Do not use on damaged or broken skin

When using this product keep out of eyes. Rinse with water to remove.

Stop use and ask a doctor if rash occurs

Keep out of reach of children. If product is swallowed, get medical help or contact a Poison Control Center right away.

Directions

For sunscreen use:

• apply liberally 15 minutes before sun exposure
• use a water resistant sunscreen if swimming or sweating
• reapply at least every 2 hours
• Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a broad spectrum SPF of 15 or higher and other sun protection measures including:
  • limit time in the sun, especially from 10 a.m. – 2 p.m.
  • wear long-sleeve shirts, pants, hats, and sunglasses
• children under 6 months: Ask a doctor

Inactive ingredients

BORON NITRIDE SYNTHETIC FLUORPHLOGOPITE NYLON-12 LAUROYL LYSINE DIMETHICONE JOJOBA ESTERS SILICA VINYL DIMETHICONE/METHICONE SILSESQUIOXANE CROSSPOLYMER TRIETHYLHEXANOIN DIPHENYL DIMETHICONE/VINYL DIPHENYL DIMETHICONE/SILSESQUIOXANE CROSSPOLYMER DIMETHICONE/VINYL DIMETHICONE CROSSPOLYMER CELLULOSE ALUMINUM HYDROXIDE CAPRYLIC/CAPRIC TRIGLYCERIDE ALUMINUM DISTEARATE SORBITAN SESQUIISOSTEARATE CHLORPHENESIN MAGNESIUM STEARATE CRITHMUM MARITIMUM EXTRACT ASCORBYL GLUCOSIDE TOCOPHEROL RETINYL PALMITATE TOCOPHERYL ACETATE ASCORBIC ACID GLYCINE SEA WATER WATER SERINE GLUTAMIC ACID ASPARTIC ACID BHT BARIUM SULFATE ALANINE LYSINE ARGININE TYROSINE PHENYLALANINE VALINE THREONINE PROLINE ISOLEUCINE HISTIDINE LEUCINE ALGAE EXTRACT PHENOXYETHANOL ALUMINA POTASSIUM SORBATE CITRIC ACID [+/- (MAY CONTAIN): MICA TITANIUM DIOXIDE IRON OXIDES BISMUTH OXYCHLORIDE]

Other information

• protect this product in this container from excessive heat and direct sun

Questions or comments?

Call toll free 1-888-788-NARS

PRINCIPAL DISPLAY PANEL - 12 g Tray Carton - Siberia

NARS

ALL DAY LUMINOUS POWDER FOUNDATION
BROAD SPECTRUM SPF 24 SUNSCREEN

NET WT. 0.42 Oz. 12 g

PRINCIPAL DISPLAY PANEL - 12 g Tray Carton - Mont Blanc

NARS

ALL DAY LUMINOUS POWDER FOUNDATION
BROAD SPECTRUM SPF 24 SUNSCREEN

NET WT. 0.42 Oz. 12 g

PRINCIPAL DISPLAY PANEL - 12 g Tray Carton - Deauville

NARS

ALL DAY LUMINOUS POWDER FOUNDATION
BROAD SPECTRUM SPF 24 SUNSCREEN

NET WT. 0.42 Oz. 12 g

PRINCIPAL DISPLAY PANEL - 12 g Tray Carton - Sweden

NARS

ALL DAY LUMINOUS POWDER FOUNDATION
BROAD SPECTRUM SPF 24 SUNSCREEN

NET WT. 0.42 Oz. 12 g

PRINCIPAL DISPLAY PANEL - 12 g Tray Carton - Fiji

NARS

ALL DAY LUMINOUS POWDER FOUNDATION
BROAD SPECTRUM SPF 24 SUNSCREEN

NET WT. 0.42 Oz. 12 g

PRINCIPAL DISPLAY PANEL - 12 g Tray Carton - Punjab

NARS

ALL DAY LUMINOUS POWDER FOUNDATION
BROAD SPECTRUM SPF 24 SUNSCREEN

NET WT. 0.42 Oz. 12 g

PRINCIPAL DISPLAY PANEL - 12 g Tray Carton - Santa Fe

NARS

ALL DAY LUMINOUS POWDER FOUNDATION
BROAD SPECTRUM SPF 24 SUNSCREEN

NET WT. 0.42 Oz. 12 g

PRINCIPAL DISPLAY PANEL - 12 g Tray Carton - Barcelona

NARS

ALL DAY LUMINOUS POWDER FOUNDATION
BROAD SPECTRUM SPF 24 SUNSCREEN

NET WT. 0.42 Oz. 12 g

PRINCIPAL DISPLAY PANEL - 12 g Tray Carton - Laponie

NARS

ALL DAY LUMINOUS POWDER FOUNDATION
BROAD SPECTRUM SPF 24 SUNSCREEN

NET WT. 0.42 Oz. 12 g

PRINCIPAL DISPLAY PANEL - 12 g Tray Carton - Vallauris

NARS

ALL DAY LUMINOUS POWDER FOUNDATION
BROAD SPECTRUM SPF 24 SUNSCREEN

NET WT. 0.42 Oz. 12 g

INGREDIENTS AND APPEARANCE

NARS ALL DAY LUMINOUS FOUNDATION   SIBERIA
octinoxate and titanium dioxide powder

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 13734-129
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
Octinoxate (UNII: 4Y5P7MUD51) (Octinoxate - UNII:4Y5P7MUD51)	Octinoxate	588 mg  in 12 g
Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP)	Titanium Dioxide	996 mg  in 12 g

Inactive Ingredients
Ingredient Name	Strength
MICA (UNII: V8A1AW0880)
BORON NITRIDE (UNII: 2U4T60A6YD)
BISMUTH OXYCHLORIDE (UNII: 4ZR792I587)
NYLON-12 (UNII: 446U8J075B)
FERRIC OXIDE RED (UNII: 1K09F3G675)
LAUROYL LYSINE (UNII: 113171Q70B)
DIMETHICONE (UNII: 92RU3N3Y1O)
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
TRIETHYLHEXANOIN (UNII: 7K3W1BIU6K)
.ALPHA.-CELLULOSE (UNII: I355QGZ19A)
ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0)
MEDIUM-CHAIN TRIGLYCERIDES (UNII: C9H2L21V7U)
ALUMINUM DISTEARATE (UNII: 7P1HP1B9UI)
FERRIC OXIDE YELLOW (UNII: EX438O2MRT)
FERROSOFERRIC OXIDE (UNII: XM0M87F357)
CHLORPHENESIN (UNII: I670DAL4SZ)
MAGNESIUM STEARATE (UNII: 70097M6I30)
CRITHMUM MARITIMUM (UNII: J7IHY79BKY)
ASCORBYL GLUCOSIDE (UNII: 2V52R0NHXW)
.ALPHA.-TOCOPHEROL (UNII: H4N855PNZ1)
VITAMIN A PALMITATE (UNII: 1D1K0N0VVC)
.ALPHA.-TOCOPHEROL ACETATE, DL- (UNII: WR1WPI7EW8)
ASCORBIC ACID (UNII: PQ6CK8PD0R)
GLYCINE (UNII: TE7660XO1C)
SODIUM CHLORIDE (UNII: 451W47IQ8X)
WATER (UNII: 059QF0KO0R)
SERINE (UNII: 452VLY9402)
GLUTAMIC ACID (UNII: 3KX376GY7L)
BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K)
ASPARTIC ACID (UNII: 30KYC7MIAI)
BARIUM SULFATE (UNII: 25BB7EKE2E)
ALANINE (UNII: OF5P57N2ZX)
LYSINE (UNII: K3Z4F929H6)
ARGININE (UNII: 94ZLA3W45F)
TYROSINE (UNII: 42HK56048U)
PHENYLALANINE (UNII: 47E5O17Y3R)
THREONINE (UNII: 2ZD004190S)
VALINE (UNII: HG18B9YRS7)
PROLINE (UNII: 9DLQ4CIU6V)
ISOLEUCINE (UNII: 04Y7590D77)
HISTIDINE (UNII: 4QD397987E)
LEUCINE (UNII: GMW67QNF9C)
PHENOXYETHANOL (UNII: HIE492ZZ3T)
ALUMINUM OXIDE (UNII: LMI26O6933)
POTASSIUM SORBATE (UNII: 1VPU26JZZ4)
CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)
VINYL DIMETHICONE/METHICONE SILSESQUIOXANE CROSSPOLYMER (UNII: 9NH1UDD2RR)
SORBITAN SESQUIISOSTEARATE (UNII: VU97D01BF9)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 13734-129-30	1 in 1 CARTON	10/01/2014
1		12 g in 1 TRAY; Type 0: Not a Combination Product

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC MONOGRAPH NOT FINAL	part352	10/01/2014

NARS ALL DAY LUMINOUS FOUNDATION   MONT BLANC
octinoxate and titanium dioxide powder

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 13734-130
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
Octinoxate (UNII: 4Y5P7MUD51) (Octinoxate - UNII:4Y5P7MUD51)	Octinoxate	588 mg  in 12 g
Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP)	Titanium Dioxide	996 mg  in 12 g

Inactive Ingredients
Ingredient Name	Strength
MICA (UNII: V8A1AW0880)
BORON NITRIDE (UNII: 2U4T60A6YD)
BISMUTH OXYCHLORIDE (UNII: 4ZR792I587)
NYLON-12 (UNII: 446U8J075B)
FERRIC OXIDE RED (UNII: 1K09F3G675)
LAUROYL LYSINE (UNII: 113171Q70B)
DIMETHICONE (UNII: 92RU3N3Y1O)
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
TRIETHYLHEXANOIN (UNII: 7K3W1BIU6K)
.ALPHA.-CELLULOSE (UNII: I355QGZ19A)
ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0)
MEDIUM-CHAIN TRIGLYCERIDES (UNII: C9H2L21V7U)
ALUMINUM DISTEARATE (UNII: 7P1HP1B9UI)
FERRIC OXIDE YELLOW (UNII: EX438O2MRT)
FERROSOFERRIC OXIDE (UNII: XM0M87F357)
CHLORPHENESIN (UNII: I670DAL4SZ)
MAGNESIUM STEARATE (UNII: 70097M6I30)
CRITHMUM MARITIMUM (UNII: J7IHY79BKY)
ASCORBYL GLUCOSIDE (UNII: 2V52R0NHXW)
.ALPHA.-TOCOPHEROL (UNII: H4N855PNZ1)
VITAMIN A PALMITATE (UNII: 1D1K0N0VVC)
.ALPHA.-TOCOPHEROL ACETATE, DL- (UNII: WR1WPI7EW8)
ASCORBIC ACID (UNII: PQ6CK8PD0R)
GLYCINE (UNII: TE7660XO1C)
SODIUM CHLORIDE (UNII: 451W47IQ8X)
WATER (UNII: 059QF0KO0R)
SERINE (UNII: 452VLY9402)
GLUTAMIC ACID (UNII: 3KX376GY7L)
BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K)
ASPARTIC ACID (UNII: 30KYC7MIAI)
BARIUM SULFATE (UNII: 25BB7EKE2E)
ALANINE (UNII: OF5P57N2ZX)
LYSINE (UNII: K3Z4F929H6)
ARGININE (UNII: 94ZLA3W45F)
TYROSINE (UNII: 42HK56048U)
PHENYLALANINE (UNII: 47E5O17Y3R)
THREONINE (UNII: 2ZD004190S)
VALINE (UNII: HG18B9YRS7)
PROLINE (UNII: 9DLQ4CIU6V)
ISOLEUCINE (UNII: 04Y7590D77)
HISTIDINE (UNII: 4QD397987E)
LEUCINE (UNII: GMW67QNF9C)
PHENOXYETHANOL (UNII: HIE492ZZ3T)
ALUMINUM OXIDE (UNII: LMI26O6933)
POTASSIUM SORBATE (UNII: 1VPU26JZZ4)
CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)
VINYL DIMETHICONE/METHICONE SILSESQUIOXANE CROSSPOLYMER (UNII: 9NH1UDD2RR)
SORBITAN SESQUIISOSTEARATE (UNII: VU97D01BF9)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 13734-130-30	1 in 1 CARTON	10/01/2014
1		12 g in 1 TRAY; Type 0: Not a Combination Product

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC MONOGRAPH NOT FINAL	part352	10/01/2014

NARS ALL DAY LUMINOUS FOUNDATION   DEAUVILLE
octinoxate and titanium dioxide powder

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 13734-131
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
Octinoxate (UNII: 4Y5P7MUD51) (Octinoxate - UNII:4Y5P7MUD51)	Octinoxate	588 mg  in 12 g
Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP)	Titanium Dioxide	996 mg  in 12 g

Inactive Ingredients
Ingredient Name	Strength
MICA (UNII: V8A1AW0880)
BORON NITRIDE (UNII: 2U4T60A6YD)
BISMUTH OXYCHLORIDE (UNII: 4ZR792I587)
NYLON-12 (UNII: 446U8J075B)
FERRIC OXIDE RED (UNII: 1K09F3G675)
LAUROYL LYSINE (UNII: 113171Q70B)
DIMETHICONE (UNII: 92RU3N3Y1O)
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
TRIETHYLHEXANOIN (UNII: 7K3W1BIU6K)
.ALPHA.-CELLULOSE (UNII: I355QGZ19A)
ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0)
MEDIUM-CHAIN TRIGLYCERIDES (UNII: C9H2L21V7U)
ALUMINUM DISTEARATE (UNII: 7P1HP1B9UI)
FERRIC OXIDE YELLOW (UNII: EX438O2MRT)
FERROSOFERRIC OXIDE (UNII: XM0M87F357)
CHLORPHENESIN (UNII: I670DAL4SZ)
MAGNESIUM STEARATE (UNII: 70097M6I30)
CRITHMUM MARITIMUM (UNII: J7IHY79BKY)
ASCORBYL GLUCOSIDE (UNII: 2V52R0NHXW)
.ALPHA.-TOCOPHEROL (UNII: H4N855PNZ1)
VITAMIN A PALMITATE (UNII: 1D1K0N0VVC)
.ALPHA.-TOCOPHEROL ACETATE, DL- (UNII: WR1WPI7EW8)
ASCORBIC ACID (UNII: PQ6CK8PD0R)
GLYCINE (UNII: TE7660XO1C)
SODIUM CHLORIDE (UNII: 451W47IQ8X)
WATER (UNII: 059QF0KO0R)
SERINE (UNII: 452VLY9402)
GLUTAMIC ACID (UNII: 3KX376GY7L)
BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K)
ASPARTIC ACID (UNII: 30KYC7MIAI)
BARIUM SULFATE (UNII: 25BB7EKE2E)
ALANINE (UNII: OF5P57N2ZX)
LYSINE (UNII: K3Z4F929H6)
ARGININE (UNII: 94ZLA3W45F)
TYROSINE (UNII: 42HK56048U)
PHENYLALANINE (UNII: 47E5O17Y3R)
THREONINE (UNII: 2ZD004190S)
VALINE (UNII: HG18B9YRS7)
PROLINE (UNII: 9DLQ4CIU6V)
ISOLEUCINE (UNII: 04Y7590D77)
HISTIDINE (UNII: 4QD397987E)
LEUCINE (UNII: GMW67QNF9C)
PHENOXYETHANOL (UNII: HIE492ZZ3T)
ALUMINUM OXIDE (UNII: LMI26O6933)
POTASSIUM SORBATE (UNII: 1VPU26JZZ4)
CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)
VINYL DIMETHICONE/METHICONE SILSESQUIOXANE CROSSPOLYMER (UNII: 9NH1UDD2RR)
SORBITAN SESQUIISOSTEARATE (UNII: VU97D01BF9)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 13734-131-30	1 in 1 CARTON	10/01/2014
1		12 g in 1 TRAY; Type 0: Not a Combination Product

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC MONOGRAPH NOT FINAL	part352	10/01/2014

NARS ALL DAY LUMINOUS FOUNDATION   SWEDEN
octinoxate and titanium dioxide powder

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 13734-132
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
Octinoxate (UNII: 4Y5P7MUD51) (Octinoxate - UNII:4Y5P7MUD51)	Octinoxate	588 mg  in 12 g
Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP)	Titanium Dioxide	996 mg  in 12 g

Inactive Ingredients
Ingredient Name	Strength
MICA (UNII: V8A1AW0880)
BORON NITRIDE (UNII: 2U4T60A6YD)
BISMUTH OXYCHLORIDE (UNII: 4ZR792I587)
NYLON-12 (UNII: 446U8J075B)
FERRIC OXIDE RED (UNII: 1K09F3G675)
LAUROYL LYSINE (UNII: 113171Q70B)
DIMETHICONE (UNII: 92RU3N3Y1O)
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
TRIETHYLHEXANOIN (UNII: 7K3W1BIU6K)
.ALPHA.-CELLULOSE (UNII: I355QGZ19A)
ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0)
MEDIUM-CHAIN TRIGLYCERIDES (UNII: C9H2L21V7U)
ALUMINUM DISTEARATE (UNII: 7P1HP1B9UI)
FERRIC OXIDE YELLOW (UNII: EX438O2MRT)
FERROSOFERRIC OXIDE (UNII: XM0M87F357)
CHLORPHENESIN (UNII: I670DAL4SZ)
MAGNESIUM STEARATE (UNII: 70097M6I30)
CRITHMUM MARITIMUM (UNII: J7IHY79BKY)
ASCORBYL GLUCOSIDE (UNII: 2V52R0NHXW)
.ALPHA.-TOCOPHEROL (UNII: H4N855PNZ1)
VITAMIN A PALMITATE (UNII: 1D1K0N0VVC)
.ALPHA.-TOCOPHEROL ACETATE, DL- (UNII: WR1WPI7EW8)
ASCORBIC ACID (UNII: PQ6CK8PD0R)
GLYCINE (UNII: TE7660XO1C)
SODIUM CHLORIDE (UNII: 451W47IQ8X)
WATER (UNII: 059QF0KO0R)
SERINE (UNII: 452VLY9402)
GLUTAMIC ACID (UNII: 3KX376GY7L)
BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K)
ASPARTIC ACID (UNII: 30KYC7MIAI)
BARIUM SULFATE (UNII: 25BB7EKE2E)
ALANINE (UNII: OF5P57N2ZX)
LYSINE (UNII: K3Z4F929H6)
ARGININE (UNII: 94ZLA3W45F)
TYROSINE (UNII: 42HK56048U)
PHENYLALANINE (UNII: 47E5O17Y3R)
THREONINE (UNII: 2ZD004190S)
VALINE (UNII: HG18B9YRS7)
PROLINE (UNII: 9DLQ4CIU6V)
ISOLEUCINE (UNII: 04Y7590D77)
HISTIDINE (UNII: 4QD397987E)
LEUCINE (UNII: GMW67QNF9C)
PHENOXYETHANOL (UNII: HIE492ZZ3T)
ALUMINUM OXIDE (UNII: LMI26O6933)
POTASSIUM SORBATE (UNII: 1VPU26JZZ4)
CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)
VINYL DIMETHICONE/METHICONE SILSESQUIOXANE CROSSPOLYMER (UNII: 9NH1UDD2RR)
SORBITAN SESQUIISOSTEARATE (UNII: VU97D01BF9)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 13734-132-30	1 in 1 CARTON	10/01/2014
1		12 g in 1 TRAY; Type 0: Not a Combination Product

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC MONOGRAPH NOT FINAL	part352	10/01/2014

NARS ALL DAY LUMINOUS FOUNDATION   FIJI
octinoxate and titanium dioxide powder

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 13734-133
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
Octinoxate (UNII: 4Y5P7MUD51) (Octinoxate - UNII:4Y5P7MUD51)	Octinoxate	588 mg  in 12 g
Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP)	Titanium Dioxide	996 mg  in 12 g

Inactive Ingredients
Ingredient Name	Strength
MICA (UNII: V8A1AW0880)
BORON NITRIDE (UNII: 2U4T60A6YD)
BISMUTH OXYCHLORIDE (UNII: 4ZR792I587)
NYLON-12 (UNII: 446U8J075B)
FERRIC OXIDE RED (UNII: 1K09F3G675)
LAUROYL LYSINE (UNII: 113171Q70B)
DIMETHICONE (UNII: 92RU3N3Y1O)
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
TRIETHYLHEXANOIN (UNII: 7K3W1BIU6K)
.ALPHA.-CELLULOSE (UNII: I355QGZ19A)
ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0)
MEDIUM-CHAIN TRIGLYCERIDES (UNII: C9H2L21V7U)
ALUMINUM DISTEARATE (UNII: 7P1HP1B9UI)
FERRIC OXIDE YELLOW (UNII: EX438O2MRT)
FERROSOFERRIC OXIDE (UNII: XM0M87F357)
CHLORPHENESIN (UNII: I670DAL4SZ)
MAGNESIUM STEARATE (UNII: 70097M6I30)
CRITHMUM MARITIMUM (UNII: J7IHY79BKY)
ASCORBYL GLUCOSIDE (UNII: 2V52R0NHXW)
.ALPHA.-TOCOPHEROL (UNII: H4N855PNZ1)
VITAMIN A PALMITATE (UNII: 1D1K0N0VVC)
.ALPHA.-TOCOPHEROL ACETATE, DL- (UNII: WR1WPI7EW8)
ASCORBIC ACID (UNII: PQ6CK8PD0R)
GLYCINE (UNII: TE7660XO1C)
SODIUM CHLORIDE (UNII: 451W47IQ8X)
WATER (UNII: 059QF0KO0R)
SERINE (UNII: 452VLY9402)
GLUTAMIC ACID (UNII: 3KX376GY7L)
BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K)
ASPARTIC ACID (UNII: 30KYC7MIAI)
BARIUM SULFATE (UNII: 25BB7EKE2E)
ALANINE (UNII: OF5P57N2ZX)
LYSINE (UNII: K3Z4F929H6)
ARGININE (UNII: 94ZLA3W45F)
TYROSINE (UNII: 42HK56048U)
PHENYLALANINE (UNII: 47E5O17Y3R)
THREONINE (UNII: 2ZD004190S)
VALINE (UNII: HG18B9YRS7)
PROLINE (UNII: 9DLQ4CIU6V)
ISOLEUCINE (UNII: 04Y7590D77)
HISTIDINE (UNII: 4QD397987E)
LEUCINE (UNII: GMW67QNF9C)
PHENOXYETHANOL (UNII: HIE492ZZ3T)
ALUMINUM OXIDE (UNII: LMI26O6933)
POTASSIUM SORBATE (UNII: 1VPU26JZZ4)
CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)
VINYL DIMETHICONE/METHICONE SILSESQUIOXANE CROSSPOLYMER (UNII: 9NH1UDD2RR)
SORBITAN SESQUIISOSTEARATE (UNII: VU97D01BF9)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 13734-133-30	1 in 1 CARTON	10/01/2014
1		12 g in 1 TRAY; Type 0: Not a Combination Product

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC MONOGRAPH NOT FINAL	part352	10/01/2014

NARS ALL DAY LUMINOUS FOUNDATION   PUNJAB
octinoxate and titanium dioxide powder

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 13734-134
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
Octinoxate (UNII: 4Y5P7MUD51) (Octinoxate - UNII:4Y5P7MUD51)	Octinoxate	588 mg  in 12 g
Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP)	Titanium Dioxide	996 mg  in 12 g

Inactive Ingredients
Ingredient Name	Strength
MICA (UNII: V8A1AW0880)
BORON NITRIDE (UNII: 2U4T60A6YD)
BISMUTH OXYCHLORIDE (UNII: 4ZR792I587)
NYLON-12 (UNII: 446U8J075B)
FERRIC OXIDE RED (UNII: 1K09F3G675)
LAUROYL LYSINE (UNII: 113171Q70B)
DIMETHICONE (UNII: 92RU3N3Y1O)
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
TRIETHYLHEXANOIN (UNII: 7K3W1BIU6K)
.ALPHA.-CELLULOSE (UNII: I355QGZ19A)
ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0)
MEDIUM-CHAIN TRIGLYCERIDES (UNII: C9H2L21V7U)
ALUMINUM DISTEARATE (UNII: 7P1HP1B9UI)
FERRIC OXIDE YELLOW (UNII: EX438O2MRT)
FERROSOFERRIC OXIDE (UNII: XM0M87F357)
CHLORPHENESIN (UNII: I670DAL4SZ)
MAGNESIUM STEARATE (UNII: 70097M6I30)
CRITHMUM MARITIMUM (UNII: J7IHY79BKY)
ASCORBYL GLUCOSIDE (UNII: 2V52R0NHXW)
.ALPHA.-TOCOPHEROL (UNII: H4N855PNZ1)
VITAMIN A PALMITATE (UNII: 1D1K0N0VVC)
.ALPHA.-TOCOPHEROL ACETATE, DL- (UNII: WR1WPI7EW8)
ASCORBIC ACID (UNII: PQ6CK8PD0R)
GLYCINE (UNII: TE7660XO1C)
SODIUM CHLORIDE (UNII: 451W47IQ8X)
WATER (UNII: 059QF0KO0R)
SERINE (UNII: 452VLY9402)
GLUTAMIC ACID (UNII: 3KX376GY7L)
BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K)
ASPARTIC ACID (UNII: 30KYC7MIAI)
BARIUM SULFATE (UNII: 25BB7EKE2E)
ALANINE (UNII: OF5P57N2ZX)
LYSINE (UNII: K3Z4F929H6)
ARGININE (UNII: 94ZLA3W45F)
TYROSINE (UNII: 42HK56048U)
PHENYLALANINE (UNII: 47E5O17Y3R)
THREONINE (UNII: 2ZD004190S)
VALINE (UNII: HG18B9YRS7)
PROLINE (UNII: 9DLQ4CIU6V)
ISOLEUCINE (UNII: 04Y7590D77)
HISTIDINE (UNII: 4QD397987E)
LEUCINE (UNII: GMW67QNF9C)
PHENOXYETHANOL (UNII: HIE492ZZ3T)
ALUMINUM OXIDE (UNII: LMI26O6933)
POTASSIUM SORBATE (UNII: 1VPU26JZZ4)
CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)
VINYL DIMETHICONE/METHICONE SILSESQUIOXANE CROSSPOLYMER (UNII: 9NH1UDD2RR)
SORBITAN SESQUIISOSTEARATE (UNII: VU97D01BF9)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 13734-134-30	1 in 1 CARTON	10/01/2014
1		12 g in 1 TRAY; Type 0: Not a Combination Product

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC MONOGRAPH NOT FINAL	part352	10/01/2014

NARS ALL DAY LUMINOUS FOUNDATION   SANTA FE
octinoxate and titanium dioxide powder

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 13734-135
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
Octinoxate (UNII: 4Y5P7MUD51) (Octinoxate - UNII:4Y5P7MUD51)	Octinoxate	588 mg  in 12 g
Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP)	Titanium Dioxide	996 mg  in 12 g

Inactive Ingredients
Ingredient Name	Strength
MICA (UNII: V8A1AW0880)
BORON NITRIDE (UNII: 2U4T60A6YD)
BISMUTH OXYCHLORIDE (UNII: 4ZR792I587)
NYLON-12 (UNII: 446U8J075B)
FERRIC OXIDE RED (UNII: 1K09F3G675)
LAUROYL LYSINE (UNII: 113171Q70B)
DIMETHICONE (UNII: 92RU3N3Y1O)
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
TRIETHYLHEXANOIN (UNII: 7K3W1BIU6K)
.ALPHA.-CELLULOSE (UNII: I355QGZ19A)
ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0)
MEDIUM-CHAIN TRIGLYCERIDES (UNII: C9H2L21V7U)
ALUMINUM DISTEARATE (UNII: 7P1HP1B9UI)
FERRIC OXIDE YELLOW (UNII: EX438O2MRT)
FERROSOFERRIC OXIDE (UNII: XM0M87F357)
CHLORPHENESIN (UNII: I670DAL4SZ)
MAGNESIUM STEARATE (UNII: 70097M6I30)
CRITHMUM MARITIMUM (UNII: J7IHY79BKY)
ASCORBYL GLUCOSIDE (UNII: 2V52R0NHXW)
.ALPHA.-TOCOPHEROL (UNII: H4N855PNZ1)
VITAMIN A PALMITATE (UNII: 1D1K0N0VVC)
.ALPHA.-TOCOPHEROL ACETATE, DL- (UNII: WR1WPI7EW8)
ASCORBIC ACID (UNII: PQ6CK8PD0R)
GLYCINE (UNII: TE7660XO1C)
SODIUM CHLORIDE (UNII: 451W47IQ8X)
WATER (UNII: 059QF0KO0R)
SERINE (UNII: 452VLY9402)
GLUTAMIC ACID (UNII: 3KX376GY7L)
BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K)
ASPARTIC ACID (UNII: 30KYC7MIAI)
BARIUM SULFATE (UNII: 25BB7EKE2E)
ALANINE (UNII: OF5P57N2ZX)
LYSINE (UNII: K3Z4F929H6)
ARGININE (UNII: 94ZLA3W45F)
TYROSINE (UNII: 42HK56048U)
PHENYLALANINE (UNII: 47E5O17Y3R)
THREONINE (UNII: 2ZD004190S)
VALINE (UNII: HG18B9YRS7)
PROLINE (UNII: 9DLQ4CIU6V)
ISOLEUCINE (UNII: 04Y7590D77)
HISTIDINE (UNII: 4QD397987E)
LEUCINE (UNII: GMW67QNF9C)
PHENOXYETHANOL (UNII: HIE492ZZ3T)
ALUMINUM OXIDE (UNII: LMI26O6933)
POTASSIUM SORBATE (UNII: 1VPU26JZZ4)
CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)
VINYL DIMETHICONE/METHICONE SILSESQUIOXANE CROSSPOLYMER (UNII: 9NH1UDD2RR)
SORBITAN SESQUIISOSTEARATE (UNII: VU97D01BF9)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 13734-135-30	1 in 1 CARTON	10/01/2014
1		12 g in 1 TRAY; Type 0: Not a Combination Product

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC MONOGRAPH NOT FINAL	part352	10/01/2014

NARS ALL DAY LUMINOUS FOUNDATION   BARCELONA
octinoxate and titanium dioxide powder

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 13734-136
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
Octinoxate (UNII: 4Y5P7MUD51) (Octinoxate - UNII:4Y5P7MUD51)	Octinoxate	588 mg  in 12 g
Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP)	Titanium Dioxide	996 mg  in 12 g

Inactive Ingredients
Ingredient Name	Strength
MICA (UNII: V8A1AW0880)
BORON NITRIDE (UNII: 2U4T60A6YD)
BISMUTH OXYCHLORIDE (UNII: 4ZR792I587)
NYLON-12 (UNII: 446U8J075B)
FERRIC OXIDE RED (UNII: 1K09F3G675)
LAUROYL LYSINE (UNII: 113171Q70B)
DIMETHICONE (UNII: 92RU3N3Y1O)
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
TRIETHYLHEXANOIN (UNII: 7K3W1BIU6K)
.ALPHA.-CELLULOSE (UNII: I355QGZ19A)
ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0)
MEDIUM-CHAIN TRIGLYCERIDES (UNII: C9H2L21V7U)
ALUMINUM DISTEARATE (UNII: 7P1HP1B9UI)
FERRIC OXIDE YELLOW (UNII: EX438O2MRT)
FERROSOFERRIC OXIDE (UNII: XM0M87F357)
CHLORPHENESIN (UNII: I670DAL4SZ)
MAGNESIUM STEARATE (UNII: 70097M6I30)
CRITHMUM MARITIMUM (UNII: J7IHY79BKY)
ASCORBYL GLUCOSIDE (UNII: 2V52R0NHXW)
.ALPHA.-TOCOPHEROL (UNII: H4N855PNZ1)
VITAMIN A PALMITATE (UNII: 1D1K0N0VVC)
.ALPHA.-TOCOPHEROL ACETATE, DL- (UNII: WR1WPI7EW8)
ASCORBIC ACID (UNII: PQ6CK8PD0R)
GLYCINE (UNII: TE7660XO1C)
SODIUM CHLORIDE (UNII: 451W47IQ8X)
WATER (UNII: 059QF0KO0R)
SERINE (UNII: 452VLY9402)
GLUTAMIC ACID (UNII: 3KX376GY7L)
BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K)
ASPARTIC ACID (UNII: 30KYC7MIAI)
BARIUM SULFATE (UNII: 25BB7EKE2E)
ALANINE (UNII: OF5P57N2ZX)
LYSINE (UNII: K3Z4F929H6)
ARGININE (UNII: 94ZLA3W45F)
TYROSINE (UNII: 42HK56048U)
PHENYLALANINE (UNII: 47E5O17Y3R)
THREONINE (UNII: 2ZD004190S)
VALINE (UNII: HG18B9YRS7)
PROLINE (UNII: 9DLQ4CIU6V)
ISOLEUCINE (UNII: 04Y7590D77)
HISTIDINE (UNII: 4QD397987E)
LEUCINE (UNII: GMW67QNF9C)
PHENOXYETHANOL (UNII: HIE492ZZ3T)
ALUMINUM OXIDE (UNII: LMI26O6933)
POTASSIUM SORBATE (UNII: 1VPU26JZZ4)
CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)
VINYL DIMETHICONE/METHICONE SILSESQUIOXANE CROSSPOLYMER (UNII: 9NH1UDD2RR)
SORBITAN SESQUIISOSTEARATE (UNII: VU97D01BF9)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 13734-136-30	1 in 1 CARTON	10/01/2014
1		12 g in 1 TRAY; Type 0: Not a Combination Product

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC MONOGRAPH NOT FINAL	part352	10/01/2014

NARS ALL DAY LUMINOUS FOUNDATION   LAPONIE
octinoxate and titanium dioxide powder

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 13734-137
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
Octinoxate (UNII: 4Y5P7MUD51) (Octinoxate - UNII:4Y5P7MUD51)	Octinoxate	588 mg  in 12 g
Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP)	Titanium Dioxide	996 mg  in 12 g

Inactive Ingredients
Ingredient Name	Strength
MICA (UNII: V8A1AW0880)
BORON NITRIDE (UNII: 2U4T60A6YD)
BISMUTH OXYCHLORIDE (UNII: 4ZR792I587)
NYLON-12 (UNII: 446U8J075B)
FERRIC OXIDE RED (UNII: 1K09F3G675)
LAUROYL LYSINE (UNII: 113171Q70B)
DIMETHICONE (UNII: 92RU3N3Y1O)
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
TRIETHYLHEXANOIN (UNII: 7K3W1BIU6K)
.ALPHA.-CELLULOSE (UNII: I355QGZ19A)
ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0)
MEDIUM-CHAIN TRIGLYCERIDES (UNII: C9H2L21V7U)
ALUMINUM DISTEARATE (UNII: 7P1HP1B9UI)
FERRIC OXIDE YELLOW (UNII: EX438O2MRT)
FERROSOFERRIC OXIDE (UNII: XM0M87F357)
CHLORPHENESIN (UNII: I670DAL4SZ)
MAGNESIUM STEARATE (UNII: 70097M6I30)
CRITHMUM MARITIMUM (UNII: J7IHY79BKY)
ASCORBYL GLUCOSIDE (UNII: 2V52R0NHXW)
.ALPHA.-TOCOPHEROL (UNII: H4N855PNZ1)
VITAMIN A PALMITATE (UNII: 1D1K0N0VVC)
.ALPHA.-TOCOPHEROL ACETATE, DL- (UNII: WR1WPI7EW8)
ASCORBIC ACID (UNII: PQ6CK8PD0R)
GLYCINE (UNII: TE7660XO1C)
SODIUM CHLORIDE (UNII: 451W47IQ8X)
WATER (UNII: 059QF0KO0R)
SERINE (UNII: 452VLY9402)
GLUTAMIC ACID (UNII: 3KX376GY7L)
BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K)
ASPARTIC ACID (UNII: 30KYC7MIAI)
BARIUM SULFATE (UNII: 25BB7EKE2E)
ALANINE (UNII: OF5P57N2ZX)
LYSINE (UNII: K3Z4F929H6)
ARGININE (UNII: 94ZLA3W45F)
TYROSINE (UNII: 42HK56048U)
PHENYLALANINE (UNII: 47E5O17Y3R)
THREONINE (UNII: 2ZD004190S)
VALINE (UNII: HG18B9YRS7)
PROLINE (UNII: 9DLQ4CIU6V)
ISOLEUCINE (UNII: 04Y7590D77)
HISTIDINE (UNII: 4QD397987E)
LEUCINE (UNII: GMW67QNF9C)
PHENOXYETHANOL (UNII: HIE492ZZ3T)
ALUMINUM OXIDE (UNII: LMI26O6933)
POTASSIUM SORBATE (UNII: 1VPU26JZZ4)
CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)
VINYL DIMETHICONE/METHICONE SILSESQUIOXANE CROSSPOLYMER (UNII: 9NH1UDD2RR)
SORBITAN SESQUIISOSTEARATE (UNII: VU97D01BF9)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 13734-137-30	1 in 1 CARTON	10/01/2014
1		12 g in 1 TRAY; Type 0: Not a Combination Product

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC MONOGRAPH NOT FINAL	part352	10/01/2014

NARS ALL DAY LUMINOUS FOUNDATION   VALLAURIS
octinoxate and titanium dioxide powder

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 13734-138
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
Octinoxate (UNII: 4Y5P7MUD51) (Octinoxate - UNII:4Y5P7MUD51)	Octinoxate	588 mg  in 12 g
Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP)	Titanium Dioxide	996 mg  in 12 g

Inactive Ingredients
Ingredient Name	Strength
MICA (UNII: V8A1AW0880)
BORON NITRIDE (UNII: 2U4T60A6YD)
BISMUTH OXYCHLORIDE (UNII: 4ZR792I587)
NYLON-12 (UNII: 446U8J075B)
FERRIC OXIDE RED (UNII: 1K09F3G675)
LAUROYL LYSINE (UNII: 113171Q70B)
DIMETHICONE (UNII: 92RU3N3Y1O)
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
TRIETHYLHEXANOIN (UNII: 7K3W1BIU6K)
.ALPHA.-CELLULOSE (UNII: I355QGZ19A)
ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0)
MEDIUM-CHAIN TRIGLYCERIDES (UNII: C9H2L21V7U)
ALUMINUM DISTEARATE (UNII: 7P1HP1B9UI)
FERRIC OXIDE YELLOW (UNII: EX438O2MRT)
FERROSOFERRIC OXIDE (UNII: XM0M87F357)
CHLORPHENESIN (UNII: I670DAL4SZ)
MAGNESIUM STEARATE (UNII: 70097M6I30)
CRITHMUM MARITIMUM (UNII: J7IHY79BKY)
ASCORBYL GLUCOSIDE (UNII: 2V52R0NHXW)
.ALPHA.-TOCOPHEROL (UNII: H4N855PNZ1)
VITAMIN A PALMITATE (UNII: 1D1K0N0VVC)
.ALPHA.-TOCOPHEROL ACETATE, DL- (UNII: WR1WPI7EW8)
ASCORBIC ACID (UNII: PQ6CK8PD0R)
GLYCINE (UNII: TE7660XO1C)
SODIUM CHLORIDE (UNII: 451W47IQ8X)
WATER (UNII: 059QF0KO0R)
SERINE (UNII: 452VLY9402)
GLUTAMIC ACID (UNII: 3KX376GY7L)
BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K)
ASPARTIC ACID (UNII: 30KYC7MIAI)
BARIUM SULFATE (UNII: 25BB7EKE2E)
ALANINE (UNII: OF5P57N2ZX)
LYSINE (UNII: K3Z4F929H6)
ARGININE (UNII: 94ZLA3W45F)
TYROSINE (UNII: 42HK56048U)
PHENYLALANINE (UNII: 47E5O17Y3R)
THREONINE (UNII: 2ZD004190S)
VALINE (UNII: HG18B9YRS7)
PROLINE (UNII: 9DLQ4CIU6V)
ISOLEUCINE (UNII: 04Y7590D77)
HISTIDINE (UNII: 4QD397987E)
LEUCINE (UNII: GMW67QNF9C)
PHENOXYETHANOL (UNII: HIE492ZZ3T)
ALUMINUM OXIDE (UNII: LMI26O6933)
POTASSIUM SORBATE (UNII: 1VPU26JZZ4)
CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)
VINYL DIMETHICONE/METHICONE SILSESQUIOXANE CROSSPOLYMER (UNII: 9NH1UDD2RR)
SORBITAN SESQUIISOSTEARATE (UNII: VU97D01BF9)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 13734-138-30	1 in 1 CARTON	10/01/2014
1		12 g in 1 TRAY; Type 0: Not a Combination Product

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC MONOGRAPH NOT FINAL	part352	10/01/2014

Labeler - NARS COSMETICS (837363571)